The distribution and function of sympathetic innervation in skeletal muscle have largely remained elusive. Here we demonstrate that sympathetic neurons make close contact with neuromuscular junctions and form a network in skeletal muscle that may functionally couple different targets including blood vessels, motor neurons, and muscle fibers. Direct stimulation of sympathetic neurons led to activation of muscle postsynaptic β2-adrenoreceptor (ADRB2), cAMP production, and import of the transcriptional coactivator peroxisome proliferator-activated receptor γ-coactivator 1α (PPARGC1A) into myonuclei. Electrophysiological and morphological deficits of neuromuscular junctions upon sympathectomy and in myasthenic mice were rescued by sympathicomimetic treatment. In conclusion, this study identifies the neuromuscular junction as a target of the sympathetic nervous system and shows that sympathetic input is crucial for synapse maintenance and function. neuromuscular junction | sympathetic neurons | cAMP | beta-agonists | myasthenia W ith the exception of the regulation of blood vessel smooth muscle tonus, functions of sympathetic neurons in skeletal muscle have scarcely been explored (1, 2) . Recently, sympathicomimetics (SM) have been introduced successfully as clinical treatment of neuromuscular transmission disorders called congenital myasthenic syndromes (CMSs) (3, 4) . Fittingly, muscle weakness is a hallmark of several autonomous nervous system disorders, including chronic fatigue syndrome (5) , congenital insensitivity to pain (6) , adrenal insufficiency (7, 8) , complex regional pain syndromes (9, 10) , and Lambert-Eaton myasthenic syndrome (11) (12) (13) . Because, furthermore, beta-blockers lead to increased susceptibility to muscle fatigue (14) and modulate neuromuscular activity of drugs applied during anesthesia (15), we became interested in addressing sympathetic innervation of skeletal muscle.
Results

A Network of Sympathetic Neurons Contacts Different Targets in
Skeletal Muscle. To investigate the distribution of sympathetic neurons in mouse skeletal muscle, we used reporter mice expressing Tomato protein under control of the dopamine β-hydroxylase (DBH) promoter (16) (DBH-Tomato). Tomato colocalized with immunofluorescence (IF) signals of the sympathetic markers tyrosine hydroxylase (TH) (Fig. 1A ) and neuropeptide Y (Fig. S1 ). Sympathetic neurons were present in large amounts throughout the diaphragm muscle (Fig. 1A and Fig. S1A ). Axons either innervated or passed in proximity to neuromuscular junctions (NMJs) that were stained with fluorescent alpha-bungarotoxin conjugate (BGT-AF647) (Fig. 1A and Fig. S1 ). Costaining of extensor digitorum longus (EDL) muscles with wheat germ agglutinin (WGA), TH antibody, and BGT-AF647 showed that TH-positive axons were associated with blood vessels (Fig. S2) . However, 69.86 ± 11.22% (mean ± SEM, n = 5) NMJ regions also displayed plaque-like TH immunosignals, which connected to TH-immunopositive axons. The cholinergic presynaptic marker vesicular acetylcholine transporter (VACHT) perfectly colocalized with AChRs but only partially with TH (Fig. 1B) ; 67.59 ± 8.83% (mean ± SEM, n = 10) of VACHT-positive portions of motor neuron axons (Fig. 1B , open arrowheads) were accompanied by TH-positive axons, which then formed connections to other TH-positive axons (Fig. 1B, asterisks) . Muscle transverse sections stained with anti-TH antibody and BGT demonstrated that 95.8 ± 2.6% and 90.6 ± 1.96% (both mean ± SEM, n = 4) of NMJ regions were TH-immunopositive in EDL and soleus muscles, respectively (Fig. 1D ).
Significance
The sympathetic nervous system regulates basic body functions such as heartbeat, blood pressure, and gland activities. Whereas hormone secretion from the adrenal medulla modulates these processes systemically, local and fast responses can be mediated by direct sympathetic innervation. Although many effects of the sympathetic system on skeletal muscle physiology and disease are known, direct sympathetic innervation targets in skeletal muscle have been scarcely studied. We investigated this aspect and found that neuromuscular junctions, the contact points between motor neurons and muscle fibers, are innervated by sympathetic neurons, which is of crucial importance for the integrity and function of nerve-muscle contact. Our findings help to understand and refine treatment of neuromuscular diseases, including myasthenic syndromes.
Functional Effects of Sympathetic Stimulation on Muscle and NMJs.
The most abundant targets of norepinephrine in skeletal muscle are β2-adrenoreceptors (ADRB2s) (17, 18) . Transverse sections of EDL were stained for ADRB2s and AChRs. Colocalization analysis showed a Pearson's coefficient of 0.70 ± 0.04 (mean ± SEM, n = 13; Fig. S3 A and B) , suggesting enrichment of ADRB2 in the NMJ. Sympathetic neuron activity on postsynaptic ADRB2 signaling was tested using the Förster resonance energy transfer (FRET)-based biosensor β2-AR-s-pep (19) , which accumulated at the NMJ (Fig. S3  C and D) . In vivo FRET imaging in combination with direct electrical stimulation of the sympathetic chain revealed a fast, sympathetic stimulation-dependent increase in postsynaptic ADRB2 activity ( Fig.  2A and Fig. S3E) . Next, to monitor postsynaptic cAMP production, a NMJ-specific cAMP sensor, termed "RAPSN-EPAC," was designed (Fig. S4) . RAPSN-EPAC, which is composed of the receptorassociated protein of the synapse (RAPSN) followed by the cAMP-binding domains of the Exchange protein directly activated by cAMP (EPAC), showed specific localization at NMJs (Fig. S4B) . In vivo imaging of RAPSN-EPAC demonstrated a consistent increase in postsynaptic cAMP levels upon direct stimulation of the sympathetic chain (Fig. 2B and Fig. S4D ).
Given the recent success of SM in CMS treatment, we next tested the effect of the SM clenbuterol on AChRα1 subunit gene (CHRNA1) activity. Clenbuterol was applied s.c. daily for 10 d. Then, the amounts of CHRNA1 mRNA were determined from harvested muscles, showing a 10.23 ± 2.0-fold increase (mean ± SEM, n = 4; P = 0.009) in SM-treated muscles compared with saline-injected controls. Given that ADRB2 activation enhances expression of peroxisome proliferator-activated receptor γ-coactivator 1α (PPARGC1A) (20) and that PPARGC1A regulates NMJ-specific genes, including CHRNA1, in an activity-dependent manner (21), we addressed the effect of sympathetic chain stimulation on cytoplasm-to-nucleus shuttling of PPARGC1A. PPARGC1A-GFP was expressed in tibialis anterior (TA) muscles, and its amount in myonuclei upon stimulation of the sympathetic chain was observed by in vivo imaging. This revealed a rapid increase of PPARGC1A-GFP in myonuclei upon sympathetic chain stimulation ( Fig. 2C and Fig. S5 ).
Effects of Sympathectomy and Rescue by Sympathicomimetics on NMJs.
To address a trophic function of sympathetic input for the NMJ, we monitored NMJ morphology in the presence or absence of chemical sympathectomy (SE) by 6-hydroxydopamine (22, 23) . As determined by IF, SE led to diminished complexity and size of NMJs (Fig. 3A) . Quantitative analysis revealed a size reduction of NMJs upon SE compared with controls by 57 ± 5% (mean ± SEM, n = 10). Colocalization of pre-and postsynaptic structures remained unaffected under this condition and clenbuterol rescued the SE-induced effects (Fig. 3A) , suggesting that they were due to lack of sympathetic activity rather than unspecific toxicity of 6-hydroxydopamine. Next, in vivo compound muscle action potentials (CMAPs) were obtained from TA muscles that were pretreated with SE and SM as just described. CMAPs from TA muscles were measured using intramuscular needle electrodes upon repetitive maximal sciatic nerve stimulation. Whereas latency (Fig.  3B, *) was unaltered in all conditions, amplitude and time to peak (Fig. 3B, # ) of CMAPs were affected upon SE (Fig. 3 B-D) . SM recovered the effects of SE on amplitude partially (Fig. 3C) and on time to peak completely (Fig. 3D) .
The efficacy of SM for many CMS patients has been proven (3, 4). Here we used a myasthenic CHRNE L269F mouse model to test the effects of SM on NMJ morphology. AChRs were labeled with BGT. Then, mice received either saline or clenbuterol for 10 d. In vivo imaging of TA muscles was performed to reveal NMJ morphology. Similar to SE-treated wild-type mice (Fig.  3A) , saline-treated myasthenic animals had aberrant NMJs with reduced size and complexity and weak BGT staining, indicating a diminished presence of AChRs. Due to scarce amounts of AChRs, many NMJs were hardly visible (Fig. 3E, Center, arrowheads) . Conversely, NMJs of SM-treated CHRNE L269F mice looked largely normal (Fig. 3E) . Compared with wild-type synapses, myasthenic NMJs were 44 ± 3% (mean ± SEM, n = 6; P = 0.003) smaller upon saline treatment but only 6 ± 14% (mean ± SEM, n = 6; P = 0.36) smaller upon clenbuterol application.
Discussion
This study addresses the distribution and functions of sympathetic neurons in skeletal muscle with several approaches. It reveals that sympathetic neurons innervate most NMJs in skeletal muscles, and that this innervation is crucial for synaptic integrity Mean ± SEM (n = 8, 5, and 5 for wt, SE, and SE+SM, respectively; ****P < 0.0001).
(D) Quantitative analysis revealed a significant reduction of time to peak upon SE and full rescue by SM. Mean ± SEM (n = 6, 5, and 5 for wt, SE, and SE+SM, respectively; **P < 0.01). (E) TA muscles of wild-type and myasthenic slow-channel CHRNE L269F mice (eL269F) received s.c. daily doses of saline or the SM clenbuterol for 10 d. At the start of s.c. treatments, NMJs were labeled with BGT-AF647. At the end of the treatment period, NMJs were imaged with in vivo confocal microscopy. Maximum z projections showing representative NMJs under the conditions indicated in the images: wt, wild type treated with saline; eL269F, eL269F treated with saline; eL269F+SM, eL269F treated with clenbuterol. and function. At this moment it cannot be concluded whether the stimulation of sympathetic neurons acts directly on skeletal muscle or indirectly via nearby blood vessels, motor neurons, or other cells. However, the sympathetic activation effect on cAMP signaling is consistent with a trophic function of sympathetic input for NMJs. The data corroborate the antagonistic activity of SE and SM with respect to expression of AChR. Previous studies have shown that a cAMP/PKA microdomain at the NMJ is important for synapse maintenance (24) (25) (26) (27) (28) . Sympathetic input at NMJs is a candidate for maintaining this microdomain. The observed import of PPARGC1A into myonuclei upon sympathetic nerve stimulation is consistent with the transcriptional changes by SM postexercise (29) . Because PPARGC1A is crucial in mitochondrial biogenesis (30) , reduced mitochondrial protein synthesis postexercise after treatment with beta-blockers (31) could be explained as well. Because sympathetic input to skeletal muscles is via the sciatic nerve, various effects using sciatic denervation as an atrophy model might also have a sympathetic contribution. Fittingly, ganglionic sympathectomy increases proteolysis in rat muscles and norepinephrine treatment of denervated rat muscles reduces mRNA levels of the atrogenes MAFbx (syn. atrogin-1) and TRIM63 (syn. MuRF1) (2) .
Future studies need to investigate whether sympathetic neurons form synaptic contacts with the NMJs or abut their neurotransmitters more distantly. Both options might be equally functional. As known from autonomous innervation of the central nervous system, monoamines, such as norepinephrine, can be distributed by volume transmission to reach several targets (32, 33) . A general modulatory role of muscle function by sympathetic tone would benefit from an organization as a nerve net that elicits effects on several tissue components. This could harmonize muscle function and local circulation similar to respiratory-cardiovascular coupling (34).
Our findings provide a possible link to the success of SM in treating CMSs, and may help to explain phenomena of muscle weakness in many autonomous nervous system disorders. It remains to be studied whether SM primarily improves sarcomeric function, neuromuscular transmission, or a mixture of both. Although SM is effective in some forms of myasthenic syndromes (NMJ pathology) (3, (35) (36) (37) and spinal muscular atrophy (motor neuron defect involving the NMJ) (38), it was not effective in a trial for facioscapulohumeral muscular dystrophy (primary muscle pathology) (39) . In clinics, sympathectomy is used to treat hyperhidrosis. Although sympathectomy is not reported to induce severe muscle weakness in patients, changes in muscle metabolism have been documented (40) . Also, sympathectomy in rabbits evoked muscle atrophy and fiber splitting (40) . Our experiments involving sympathectomy and SM treatment led to atrophy and its recovery, respectively (Fig. S6) . Given the intimate relationship between synaptic function, muscle activity, and muscle trophicity, it is unlikely that these factors can be fully separated. However, the effects of beta-blockers on muscle fatigue (14) and anesthesia (15) suggest that an important component of sympathetic activity affects synaptic integrity and function.
The data presented here are consistent with a model where sympathetic neurons coinnervate several targets in muscle, including blood vessels, motor neurons, muscle fibers, and NMJs (Fig. S7) . Complex cross-talk between these cell types might occur using feedback mechanisms that need to be addressed further. Sympathetic innervation controls muscle metabolism as well as maintenance and function of NMJs. The success of SM treatment of several forms of myasthenic syndromes should spur further elucidation of the involved signaling pathways to develop more selective and potent therapies.
Materials and Methods
Animals. All animals were kept and treated according to guidelines of the Brazilian College of Animal Experimentation and EU Directive 2010/63/EU. Experimental protocols were approved by the commission of ethics in animal research of the School of Medicine of Ribeirão Preto and national authorities in France, Germany, and the United Kingdom. Adult male and female C57BL/10J, CHRNE L269F, B6.Cg-Gt(ROSA)26Sor tm9(CAG-tdTomato)Hze /J x B6-Tg(DBH-iCre) (called DBH-Tomato) were used for experiments. Anesthesia and preparation of mice for microscopy and electrophysiology were performed as described (25) . Sciatic Denervation, Stimulation of Lumbar Sympathetic Ganglionic Chain, and Pharmacological Treatments. Sciatic denervation was as described (41) . For details regarding the stimulation of the sympathetic ganglionic chain, see Fig.  S3 . Clenbuterol solution in PBS was always freshly prepared and then injected s.c. (3 mg/kg) for 10 d before microscopy. Chemical sympathectomy used 6-hydroxydopamine (22) (in 0.3% ascorbic acid oxygen-free water), which was injected into hindlimbs (100 mg/kg) on alternate days for 2 wk before imaging.
Compound Muscle Action Potential Measurement. Mice were kept under isoflurane anesthesia. CMAP measurements were performed after saline, SE, or SE+SM treatment (Fig. 3 B-D 
